[go: up one dir, main page]

WO2009072139A8 - Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof - Google Patents

Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof Download PDF

Info

Publication number
WO2009072139A8
WO2009072139A8 PCT/IN2008/000231 IN2008000231W WO2009072139A8 WO 2009072139 A8 WO2009072139 A8 WO 2009072139A8 IN 2008000231 W IN2008000231 W IN 2008000231W WO 2009072139 A8 WO2009072139 A8 WO 2009072139A8
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
methylbenzoyl
pyrrol
salt
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000231
Other languages
French (fr)
Other versions
WO2009072139A1 (en
Inventor
Nageswara Rao Karusala
Bhausaheb Chavhan
Jebaraj Rathinapandian
Muneendra Kumar Veeranki
Purna Chandra Ray
Om Dutt Tyagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Matrix Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Ltd filed Critical Matrix Laboratories Ltd
Publication of WO2009072139A1 publication Critical patent/WO2009072139A1/en
Publication of WO2009072139A8 publication Critical patent/WO2009072139A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel process for the preparation of tolmetin sodium, by employing easily available starting material and suitable reaction conditions. This invention is further related to novel crystalline forms of tolmetin methyl ester, tolmetin and tolmetin sodium and their process for the preparation.
PCT/IN2008/000231 2007-12-07 2008-04-08 Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof Ceased WO2009072139A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2930/CHE/2007 2007-12-07
IN2930CH2007 2007-12-07

Publications (2)

Publication Number Publication Date
WO2009072139A1 WO2009072139A1 (en) 2009-06-11
WO2009072139A8 true WO2009072139A8 (en) 2009-10-22

Family

ID=39737091

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000231 Ceased WO2009072139A1 (en) 2007-12-07 2008-04-08 Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof

Country Status (1)

Country Link
WO (1) WO2009072139A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508511A1 (en) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
CN103435527B (en) * 2013-09-03 2015-09-23 张家港市信谊化工有限公司 A kind of preparation method of non-steroidal antiphlogiston tolmetin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
US3846447A (en) * 1972-08-03 1974-11-05 Mcneilab Inc Preparation of 5-aroyl-pyrroles and intermediates therefor
US4187230A (en) * 1975-05-27 1980-02-05 Ethyl Corporation Preparation of 5-aroyl-pyrrole compounds
US4213905A (en) * 1979-06-25 1980-07-22 Mcneilab, Inc. Preparation of 5-aroyl-1-loweralkylpyrrole-2-acetic acid salts
IT1320770B1 (en) * 2000-07-21 2003-12-10 Zambon Spa METHYL ESTER SYNTHESIS PROCESS OF 1-METHYL-5- (4-METHYLBENZOYL) -PYRROL-2-ACETIC ACID.

Also Published As

Publication number Publication date
WO2009072139A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
CL2007002267A1 (en) PROCEDURE FOR PREPARATION OF COMPOUNDS DERIVED FROM CARBOXYL ACID; INTERMEDIARY COMPOUNDS.
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
ZA200709028B (en) Process for the production of acetic acid
WO2009145456A3 (en) Heterocyclic derivatives
WO2007083090A3 (en) Process for the preparation of uracil derivatives
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2009037354A3 (en) Polysaccharide derived materials
WO2010001257A3 (en) Novel solid state forms of laquinimod and its sodium salt
WO2006127893A3 (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
WO2011024192A3 (en) Novel polymorphs of raltegravir
WO2009118754A3 (en) A process for preparing a stable lyophilized composition
MX2011009898A (en) Process for the preparation of propionic acid derivatives.
WO2010076805A3 (en) Novel polymorphs of sunitinib malate
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
WO2009085176A3 (en) Use of tetramic acid derivatives for controlling nematodes
WO2007108011A3 (en) Process for the preparation of highly pure donepezil
IL207431A0 (en) New process for the preparation of cyclohexanecarboxylic acid derivatives
WO2009075516A3 (en) Process for preparing pantoprazole sodium sesquihydrate
WO2009072139A8 (en) Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof
WO2010079506A3 (en) Pharmaceutical composition of aripiprazole
WO2009021943A3 (en) Novel preparation process
WO2009116072A3 (en) Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2008008327A3 (en) Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08763723

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 08763723

Country of ref document: EP

Kind code of ref document: A1